| Literature DB >> 29441102 |
Bo Yang1, Xiaoyang Sun1, Haowen Pang1, Xiangxiang Shi1, Tao Tang1, Guangpeng Zhang1, Renjin Chen1, Jing Zhang1, Hong Wu1, Sheng Lin2, Qinglian Wen2, Yunwei Han2, Jingbo Wu2.
Abstract
PURPOSE: In interstitial brachytherapy for lung tumors, the placement and alignment of the source needles are influenced by the ribs, which can affect the dose distribution. This study evaluated the change in dose to the target by comparing the dose between the actual interstitial brachytherapy plan (AIBP, what is deliverable due to anatomic constraints), and the virtual interstitial brachytherapy plan (VIBP, pretreatment-modified dose distribution).Entities:
Keywords: CTV dose; interstitial brachytherapy; lung cancer; ribs dose
Year: 2017 PMID: 29441102 PMCID: PMC5807996 DOI: 10.5114/jcb.2017.72359
Source DB: PubMed Journal: J Contemp Brachytherapy ISSN: 2081-2841
Patient characteristics
| Characteristics | Median |
|---|---|
| Total No. of patients ( | 20 |
| Gender | |
| Males | 12 |
| Females | 8 |
| Age (y) | 58 (45-70) |
| Location ( | |
| Left lung | 13 |
| Right lung | 7 |
| CTV (cm3) | 42.87 (6.90-1179.63) |
| Lungs (cm3) | 2615.21 (2312.38-3018.67) |
| Ipsilateral lung (cm3) | 1159.31 (1055.00-1571.29) |
| Ribs (cm3) | 21.95 (11.54-34.91) |
Fig. 1Computed tomography images of needle positions due to rib interference during implant. Red dots are dwell positions, red dotted line is the clinical target volume (CTV) contour, solid lines are isodose curves, green solid line is 50% of the prescription dose, red solid line is 100%, yellow solid line is 150%, and white solid line is 200%. A) Two needles that were not parallel were implanted by passing through one available gap. B) single needle implant off-centered inside the CTV
Fig. 2Example of the regular arrangement of interpolation needles in virtual interstitial brachytherapy plan. A) Virtual needles were allowed to pass through the ribs to achieve uniform arrangement in the tumor with 1 cm spacing between needles. B) One virtual central needle passing through the clinical target volume center
Dose parameters of D95 (PD = 30 Gy)
| Plans | D95 (Avg ± st. dev) Gy |
|
|---|---|---|
| VIBP | 30.09 ± 0.14 | 0.81 |
| AIBP | 30.09 ± 0.23 | < 0.01 |
| VIBP-adjusted | 45.01 ± 14.02 |
PD – prescription dose, VIBP – virtual interstitial brachytherapy plan, AIPB – actual interstitial brachytherapy plan, Dx – minimum dosage received by 95% of CTV, St. dev – standard deviation
Dose parameters of V5 for the ipsilateral lung
| Plans | V5 ([Avg ± st. dev]%) |
|
|---|---|---|
| VIBP | 21.31 ± 16.67 | < 0.01 |
| AIBP | 28.69 ± 18.81 | 0.17 |
| VIBP-adjusted | 28.73 ±18.88 |
V5 – percentage of lung volume received 5 Gy, VIBP-adjusted – revised VIBP achieved an equal value as the ipsilateral lung V5 value in AIBP
Fig. 3Regression curve of the ΔV5 and incremental dose percentage (y = 0.043x + 0.109, R = 0.62; p < 0.05)
Fig. 4Two needles were implanted into the tumor along “B” route. The “A” route, however, offered less damage to the lung, but was blocked by the ribs. The resultant dose distribution was closest to a virtual interstitial brachytherapy plan with needles in a parallel arrangement, which was not easy to achieve by hand
Fig. 53D printed mold with preset needle pinholes. The mold has fixed channels for the needles and was 2 cm thick
Fig. 63D template technology commonly used for 125I seed implants [21]